Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
<p>Table S8. Genes used for gene set analysis</p>
সংরক্ষণ করুন:
| প্রধান লেখক: | Sung-Eun Lee (14855067) (author) |
|---|---|
| অন্যান্য লেখক: | Feng Wang (14855070) (author), Maison Grefe (14855073) (author), Abel Trujillo-Ocampo (14855076) (author), Wilfredo Ruiz-Vasquez (14855079) (author), Koichi Takahashi (14855082) (author), Hussein A. Abbas (14855085) (author), Pamella Borges (14855088) (author), Dinler Amaral Antunes (14855091) (author), Gheath Al-Atrash (14855094) (author), Naval Daver (14855097) (author), Jeffrey J. Molldrem (14855100) (author), Andrew Futreal (14855103) (author), Guillermo Garcia-Manero (14855106) (author), Jin S. Im (14855109) (author) |
| প্রকাশিত: |
2025
|
| বিষয়গুলি: | |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Supplementary Table S2 from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade
অনুযায়ী: Dong-Chun Hong (16374308)
প্রকাশিত: (2025) -
Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
অনুযায়ী: Yibin Dai (16374331)
প্রকাশিত: (2025) -
Supplementary Table S2 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
অনুযায়ী: Yibin Dai (16374331)
প্রকাশিত: (2025) -
Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
অনুযায়ী: Alessio Cortellini (11023993)
প্রকাশিত: (2025) -
Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)